BCR-ABL1<sup>INS35</sup> is not uncommon in CML patients and is related to resistance and sensitivity to inhibitors in CML treatment - Response

BCR-ABL1^INS35 is not uncommon in CML patients and is related to resistance and sensitivity to inhibitors in CML treatment - Response

BCR-ABL1^INS35 is not uncommon in CML patients and is related to resistance and sensitivity to inhibitors in CML treatment - Response. Molecular Cancer Therapeutics. 9:772.

authors with profiles

JORGE E CORTES

BCR-ABL1INS35 is not uncommon in CML patients and is related to resistance and sensitivity to inhibitors in CML treatment - Response

BCR-ABL1^INS35 is not uncommon in CML patients and is related to resistance and sensitivity to inhibitors in CML treatment - Response